Gueorguieva, Ralitza
Yale University
33 papers on CoChatORCID 0000-0003-0944-5973
Most cited papers
- Verified
Self-help for binge eating disorder in primary care: a randomized controlled trial with ethnically and racially diverse obese patients
Grilo, C. M., White, M. A., Gueorguieva, R., Barnes, R. D., & Masheb, R. M. (2013) · Behaviour Research and Therapy
Eating Disorders and BehaviorsNutrition, Health and Food Behavior
Cited by 59
- Verified
Naltrexone + Bupropion Combination for the Treatment of Binge-eating Disorder with Obesity: A Randomized, Controlled Pilot Study
Grilo, C. M., Lydecker, J. A., Morgan, P. T., & Gueorguieva, R. (2021) · Clinical Therapeutics
Eating Disorders and BehaviorsPharmacology and Obesity Treatment
Cited by 59
- Verified
Clinical and Financial Outcomes Associated With a Workplace Mental Health Program Before and During the COVID-19 Pandemic
Bondar, J., Babich Morrow, C., Gueorguieva, R., Brown, M., Hawrilenko, M., Krystal, J. H., Corlett, P. R., & Chekroud, A. M. (2022) · JAMA Network Open
Workplace Health and Well-beingDigital Mental Health Interventions
Cited by 53
- Verified
Lower prefrontal cortical synaptic vesicle binding in cocaine use disorder: An exploratory 11 C‐UCB‐J positron emission tomography study in humans
Angarita, G. A., Worhunsky, P. D., Naganawa, M., Toyonaga, T., Nabulsi, N. B., Li, C. R., Esterlis, I., Skosnik, P. D., Radhakrishnan, R., Pittman, B., et al. (2022) · Addiction Biology
Neurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and Outcomes
Cited by 38
- Verified
mTORC1 inhibitor effects on rapid ketamine-induced reductions in suicidal ideation in patients with treatment-resistant depression
Averill, L. A., Averill, C. L., Gueorguieva, R., Fouda, S., Sherif, M., Ahn, K.-H., Ranganathan, M., D'Souza, D. C., Southwick, S. M., Sanacora, G., et al. (2022) · Journal of Affective Disorders
Treatment of Major DepressionElectroconvulsive Therapy Studies
Cited by 33
- Verified
Rapamycin, an Immunosuppressant and mTORC1 Inhibitor, Triples the antidepressant Response Rate of Ketamine at 2 Weeks Following Treatment: A double-blind, placebo-controlled, cross-over, randomized clinical trial
Abdallah, C., Averill, L. A., Gueorguieva, R., Goktas, S., Purohit, P., Ranganathan, M., D'Souza, D. C., Formica, R., Southwick, S. M., Duman, R. S., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory)
Treatment of Major DepressionElectroconvulsive Therapy Studies
Cited by 30
- Verified
Cortisol levels in relation to hippocampal sub-regions in subjects with first episode schizophrenia
Gunduz-Bruce, H., Szeszko, P. R., Gueorguieva, R., Ashtari, M., Robinson, D. G., Kane, J. M., & Bilder, R. M. (2007) · Schizophrenia Research
Schizophrenia research and treatmentStress Responses and Cortisol
Cited by 30
- Verified
Implementing Motivational Interviewing for Substance Misuse on Medical Inpatient Units: a Randomized Controlled Trial
Martino, S., Zimbrean, P., Forray, A., Kaufman, J. S., Desan, P. H., Olmstead, T. A., Gilstad-Hayden, K., Gueorguieva, R., & Yonkers, K. A. (2019) · Journal of General Internal Medicine
Substance Abuse Treatment and OutcomesHealth Policy Implementation Science
Cited by 24
- Verified
An open trial of intensive cognitive-behavioral therapy for school refusal
Hannan, S., Davis, E., Morrison, S., Gueorguieva, R., & Tolin, D. F. (2019) · Evidence-Based Practice in Child and Adolescent Mental Health
Youth Substance Use and School AttendancePsychological Treatments and Assessments
Cited by 21
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free